Is This $375 Million Cannabis Stock Too Good to Be True?

Hexo (TSX:HEXO)(NYSE:HEXO) is a high-growth cannabis stock priced at a deep discount. Is this your chance to win big? Find out how to profit.

| More on:
stock data

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Following the industry bear market of 2019, many thought cannabis stocks would recover. Then came the coronavirus pandemic. Today, valuations remain 80% below their peak.

Marijuana companies are still hurting. Just look at Hexo (TSX:HEXO)(NYSE:HEXO). This $375 million business was once valued at $2 billion!

But this is far from the end. Marijuana consumption continues to rise, and companies are figuring out how to turn a hefty profit. For daring investors, this is the chance to make 10 times your original investment.

How to profit

While fortunes will be made during the next boom, not all cannabis stocks are created equal. Some will have significantly more upside.

Your best bet is to find companies that can overcome the effects of commoditization. This should be your number one priority.

Last year, before the marijuana bear market, I warned investors about the number one risk the industry faces.

“In the end, most cannabis production is not differentiated,” I explained. “That means it will sell at the same price per volume as any other cannabis.”

I stressed that the effects of commoditization will drive cannabis stocks for years to come.

“Importantly, commoditization also means that if prices get too attractive, new supply will be added to the market, pushing prices down over the long term,” I added. “Most importantly, it also means that suppliers will push hard to reduce costs; the only way to reliably make money in a commoditized market is to have a low-cost position.”

In order to profit with cannabis stocks, you need to find companies that can overcome this challenge. The best long-term strategy is through differentiation.

For example, Coca-Cola sells commoditized ingredients, but the company packages them in a way that achieves high pricing power. Consumers are willing to pay a big premium for water and sugar, as long as it says Coke on the bottle.

Marijuana companies must chart the same course. They need to figure out how to make customers loyal to value-add products that can withstand pricing erosion.

This cannabis stock will win

Despite a valuation of just $375 million, Hexo has a big lead in creating differentiated marijuana products. This was all part of its plan.

When cannabis stocks first took off in 2018, every producer rushed to bring supply online. Hexo was unique in that it focused on differentiation. That’s why it created the industry’s first cannabis platform. It provides the basic infrastructure that other brands can tap into.

For example, Hexo has a partnership with Molson Coors (TSX:TPX.B)(NYSE:TAP) to co-produce THC-infused beverages. Hexo provides the marijuana expertise, while Molson lends its globally-recognized brand.

Long term, cannabis stocks like Hexo will win. Marijuana consumption continues to grow, and certain brands will rise to the top. By partnering with existing brands that consumers already know and love, Hexo can leap ahead of the competition.

In some ways, Hexo mirrors the successful business model of tech stocks like Shopify, which simply build the basic infrastructure, allowing others to build on top. Shopify stock rose 30 times in value in just five years. Hexo could emulate that rise.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Shopify and Shopify. The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Coronavirus

Business success with growing, rising charts and businessman in background
Coronavirus

1 Growth Stock Every Canadian Investor Should Consider Right Now

This growth stock saw shares pop 10% on June 20, as one analyst stated there is a significant opportunity to…

Read more »

Aircraft wing plane
Coronavirus

Bombardier Stock Merge: What it Means for Investors

Bombardier (TSX:BBD.B) stock went through a reverse stock split on June 13, turning 25 shares into one in one swift…

Read more »

Aircraft wing plane
Coronavirus

Air Canada (TSX:AC) Stock: Ready to Take Off?

While Air Canada is handling what it can control really well, there are many worsening macro headwinds that will likely…

Read more »

rail train
Coronavirus

Bull or Bear: Why Analysts Changed Their Tune on Aecon Stock

Analysts had been champing at the bit for the construction company, but the tides have turned.

Read more »

Biotech stocks
Coronavirus

Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

Read more »

grow dividends
Coronavirus

Goodfood Stock Likely to Double in 2022!

Goodfood (TSX:FOOD) stock has had a huge rise and fall in the last few years. But at $1.85 a share,…

Read more »

grow dividends
Coronavirus

Canfor Stock Pops 5% as Sales Climb 15% YOY

Canfor (TSX:CFP) stock remained positive about its future in the global lumber market after profits climb 15% year over year.

Read more »

edit Safety First illustration
Coronavirus

2 Crash-Proof TSX Stocks I’d Buy With $5,000

These two TSX stocks have proven they can handle this economic downturn and likely will continue to be safe far…

Read more »